At a lab in River Oaks, a finger prick is all it takes to answer that question.
“We saw there was a need for people. Maybe their immunity is dropping faster, so they need to get boosted earlier. Other people could wait another two or three months and extend the overall time of their protection. You can’t do that if you don’t have a test,” said Leo Linbeck III, CEO of Brevitest.
Linbeck says their test looks for a specific antibody that’s highly correlated to protection. In 15 minutes, results are delivered electronically that show if your levels are high, low, or if you have no antibodies. You can also see how you compare to other people.
“To us, getting the numbers right is a non-negotiable. The information has to be good, because these are important decisions people are making,” said Linbeck.
Brevitest has submitted paperwork to the FDA, but have not gotten approval. Linbeck says they are allowed to keep running tests in the meantime.
“We’ve seen people 12 months after their vaccination. That count is still in the high range. For them, if they delay their booster they can extend the overall time of their protection. That has a private and public health benefit in that we’re getting longer protection in the same amount of vaccine,” said Linbeck.